Multiple Sclerosis Therapy Incorporates Stem Cells in Clinical Trial

Mesenchymal Stem Cell Therapy has been deemed safe for patients suffering from multiple sclerosis.

A recent clinical trial conducted by the University of Genoa has determined that mesenchymal stem cell therapy to treat multiple sclerosis is indeed safe to perform on humans.  27 MS patients completed the study, which comprised an injection of the patient’s own [autologous] mesenchymal stem cells [MSCs] to reduce excessive inflammation caused by the patients’ own immune systems. None of the patients suffered any side effects from the injection. Continue reading

New York Times: The Eruption of Stem Cell Therapies.

Mr. Edgar Irastorza is one of thousands of people already benefiting from the progression of stem cell based therapies.

As reported on the front page of the New York Times Science section, clinical applications of stem cell based therapies are accelerating at a rate that will revolutionize the medical field in a matter of years.  In the United States alone, there are currently over 4000 therapies in clinical trials for the treatment of heart disease, blindness, spinal cord injuries, diabetes, H.I.V., and other diseases, injuries, and traumas. Continue reading

Brain Model Created from Stem Cells.

Researchers from Tufts University utilize stem cells to create a 3-D model of the brain that replicates neurological function.

As reported in a recent article in the New York Times, bioengineers from Tufts University have created a 3-D model of the brain that, utilizing stem cell-derived neurons, the model can mimic the brain’s response to traumatic injury. Principle Investigator Dr. David Kaplan tested the model by dropping weights on it, resulting in a complete neuronal response, including the transmission of electrical impulses and chemical signals through the neurons. Continue reading

Wall Street Journal Reports on Stem Cells in Umbilical Cord Blood

Saving stem cells in cord blood ensures access to emerging regenerative therapies.

As reported by the Wall Street Journal, adult stem cell therapies are advancing rapidly; with researchers utilizing stem cells to treat an expanding range of disease, trauma and injury.  The article highlights the increasing use of cord blood to treat a variety of ailments such as; Cerebral Palsy, Traumatic Brain Injury and immune deficiencies such as diabetes. Continue reading

Stem Cells Limit Long Term Damage due to Traumatic Brain Injury

 

Inflammation due to TBI

Stem cells reduce inflammation following TBI

Researchers at the University of Texas Health Science Center have developed a novel use of stem cells to prevent neurological inflammation in patients following traumatic brain injury; potentially limiting damage caused by TBI and preserving brain function for victims.  The treatment stem cells injected into TBI-mice regulated the immune response in the brain, limiting inflammation and long term damage. Continue reading

Stem Cells Promote Regrowth of Neural Cells Following Traumatic Brain Injury

neurogenic stem cell

Transplanted neurogenic stem cells recruit host neural stem cells to site of TBI for repair.

Researchers at the University of South Florida have successfully used adult stem cells to repair traumatic brain damage in neurologically impaired mice. Prior to the study, hypotheses on how stem cells may provide treatment for neurological disorders were limited. However, the results of this experiment provide a new theory: stem cells replace dying cells while attracting other stem cells from uninjured regions of the brain to the damaged portions for continued neural cell replenishment. In the words of Principal Investigator Dr. Cesar Borlongan, “The transplanted stem cells serve as migratory cues for the brain’s own neurogenic cells.” Continue reading

UC Irvine Scientists Discuss Stem Cell Research

Dr. Peter Donovan, Dr. Hans Keirstead, Dr. Aileen Anderson, Dr. Brian Cummings, Dr. Frank LaFerla, Dr. Leslie M. Thompson, and Dr. Matthew Blurton-Jones of UC Irvine discuss the importance of stem cells and the current research taking place within their labs.

Continue reading